You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 22, 2024

NASALIDE Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


Which patents cover Nasalide, and when can generic versions of Nasalide launch?

Nasalide is a drug marketed by Ivax Res and is included in one NDA.

The generic ingredient in NASALIDE is flunisolide. There are twelve drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the flunisolide profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Nasalide

A generic version of NASALIDE was approved as flunisolide by BAUSCH on February 20th, 2002.

  Sign Up

AI Research Assistant
Questions you can ask:
  • What is the 5 year forecast for NASALIDE?
  • What are the global sales for NASALIDE?
  • What is Average Wholesale Price for NASALIDE?
Summary for NASALIDE
US Patents:0
Applicants:1
NDAs:1
Raw Ingredient (Bulk) Api Vendors: 48
Patent Applications: 4,440
DailyMed Link:NASALIDE at DailyMed
Drug patent expirations by year for NASALIDE

US Patents and Regulatory Information for NASALIDE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Ivax Res NASALIDE flunisolide SPRAY, METERED;NASAL 018148-001 Approved Prior to Jan 1, 1982 DISCN Yes No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

International Patents for NASALIDE

See the table below for patents covering NASALIDE around the world.

Country Patent Number Title Estimated Expiration
Spain 448220 ⤷  Sign Up
Philippines 13329 STABLE CRYSTALLINE PLYNISOLIDE AND COMPOSITION THEREOF ⤷  Sign Up
New Zealand 183905 AEROSOL COMPOSITIONS FOR NASAL OR INHALATION ADMINISTRATION CONTAINING 6 -FLUORO-11 , 21-DIHYDROXY-16 ,17 -ISOPROPYLIDENEDIOXY-PREGNA-1,4-DIENE-3,20-DIONE ⤷  Sign Up
>Country >Patent Number >Title >Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.